IL-21- and CXCL9-engineered GPC3-specific CAR-T cells combined with PD-1 blockade enhance cytotoxic activities against hepatocellular carcinoma-Reference-Cited by-同舟云学术

IL-21- and CXCL9-engineered GPC3-specific CAR-T cells combined with PD-1 blockade enhance cytotoxic activities against hepatocellular carcinoma

Published:2024-08-28 Issue:1 Volume:24 Page:
ISSN:1591-9528
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Chen Shanshan,Gong Fusheng,Liu Shijia,Xie Yunqing,Ye Xingming,Lin Xiaowei,Wang Xiangru,Zheng Qiuhong,Liu Qinying,Sun Yang

Funder

Startup Fund for Scientific Research, Fujian Medical University

Sciences Foundation of Fujian University Cancer Hospital

Natural Science Foundation of Fujian Province

Fujian Provincial Health Technology Project

Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, China

Joint Funds for the Innovation of Science and Technology, Fujian Province, China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10238-024-01473-2.pdf

Reference38 articles.

1. Brown ZJ, Tsilimigras DI, Ruff SM, et al. Management of hepatocellular carcinoma: a review. JAMA Surg. 2023;158(4):410–20. https://doi.org/10.1001/jamasurg.2022.7989.

2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

3. Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1–61. https://doi.org/10.1016/bs.acr.2020.10.001.

4. Zheng X, Liu X, Lei Y, Wang G, Liu M. Glypican-3: a novel and promising target for the treatment of hepatocellular carcinoma. Front Oncol. 2022;12: 824208. https://doi.org/10.3389/fonc.2022.824208.

5. Grega SD, Zheng DX, Zheng QH. Imaging ligands targeting glypican-3 receptor expression in hepatocellular carcinoma. Am J Nucl Med Mol Imaging. 2022;12(4):113–21.